Loading Events
Former FDA Oncology Reviewer Emily Place PhD MPH offers her inside perspective on IND review timelines and what drives the multidisciplinary team up to the 30 day deadline.

Join us for this brief webinar sponsored by Biologics Consulting.

 

Share This Story, Choose Your Platform!

Go to Top